🇺🇸 FDA
Patent

US 11826405

Neurotoxin compositions for use in treating headache

granted A61KA61K38/4893A61P

Quick answer

US patent 11826405 (Neurotoxin compositions for use in treating headache) held by Aeon Biopharma, Inc. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aeon Biopharma, Inc.
Grant date
Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/4893, A61P, A61P25/06, A61P25/16